16252-90-7

Basic information

• Product Name: 2-Amino-2-methylpropanamide
• Synonyms: 2-Amino-2-methylpropanamide;2-methylalaninamide(SALTDATA: HCl);2-Amino-2-methylpropionicmide hydrochloride
• CAS NO: 16252-90-7
• Molecular Formula: C₄H₁₀N₂O
• Molecular Weight: 102.135
• Mol File: 16252-90-7.mol
• Article Data: 16

Chemical Properties

• Melting Point: 260 °C
• Boiling Point: 234.7 °C at 760 mmHg
• Flash Point: 95.7 °C
• Appearance: /
• Density: 1.03 g/cm³
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• Solubility: Methanol (Sparingly)
• PKA: 15.99±0.50(Predicted)
• CAS DataBase Reference: 2-Amino-2-methylpropanamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-2-methylpropanamide(16252-90-7)
• EPA Substance Registry System: 2-Amino-2-methylpropanamide(16252-90-7)

Safety Data

• Hazardous Substances Data: 16252-90-7(Hazardous Substances Data)

Usage

Uses

2-Amino-?2-?methylpropanamide is an amino acid and a useful building block, used in the synthesis of probing mercaptobenzamides for use as HIV inactivators via nucleocapsid protein 7.

Upstream product

• 13257-67-5 2-amino-2-methylpropionic acid methyl ester 
• 50846-36-1 2-amino-2-methylpropanenitrile monohydrochloride 
• 17704-74-4 2-Amino-2-methyl-propionamide hydrochloride 
• 73470-46-9 tert-butyl (1-amino-2-methyl-1-oxopropan-2-yl)carbamate 
• 62-57-7 2-Aminoisobutyric acid 
• 19355-69-2 2-amino-2-cyanopropane 
• 16256-14-7 2-amino-2-methyl-thiopropanamide 
• 16248-81-0 (1-cyano-1-methyl-ethyl)-phosphorimidic acid trichloride 
• 81587-18-0 benzyl N-(2-amino-1,1-dimethyl-2-oxo-ethyl)carbamate 
• 15030-72-5 Z-Aib-OH 

Downstream Products

• 77-71-4 5,5-dimethyl-imidazolidine-2,4-dione 
• 666843-72-7 2-methyl-2-(2-nitrobenzenesulfonylamino)propionamide 

Relevant articles and documents

DIPEPTIDE ANALOGS AS TGF-BETA INHIBITORS

The present disclosure is concerned with dipeptide analogs that are capable of inhibiting TGF-β and methods of treating cancers such as, for example, multiple myeloma and a hematologic malignancy, methods for immunotherapy, and methods of treating fibroti

4-ISOPROPYL-6-METHOXYPHENYL GLUCITOL COMPOUND

A compound, which inhibits SGLT1 (sodium-dependent glucose transporter 1) activity to suppress absorption of glucose or the like, thereby suppressing abnormal glucose tolerance or postprandial hyperglycemia in diabetes, is provided. Specifically, a 4-isopropyl-6-methoxyphenyl glucitol compound represented by the following formula (I), or a pharmaceutically acceptable salt thereof, is provided:

Methods and compositions for treating amyloid-related diseases

Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.